Topics:

Heart Genomics wins state cash for heart failure Dx development

Tools

Florida's Heart Genomics secured a new state investment it will use to develop molecular diagnostic tests for heart failure patients. The Institute for the Commercialization of Public Research, a nonprofit state entity launched in 2007, is providing the undisclosed funding amount. Heart Genomics describes the new cash infusion as "matching funding." The new diagnostic tests are based on work developed at the University of Miami's Interdisciplinary Stem Cell Institute. Release